BioCryst Announces Positive Results from Two Phase 2 Trials

News   Aug 01, 2012

 
BioCryst Announces Positive Results from Two Phase 2 Trials
 
 
 

RELATED ARTICLES

Key Psychiatric Drug Target Comes Into Focus

News

Researchers have determined the crystal structure of a specific dopamine receptor called D4 at an incredibly high resolution which is a major step towards designing improved psychiatric drugs with fewer side effects.

READ MORE

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News

Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.

READ MORE

Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

News

Scientists performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE